NEIL ECKARD: Open Payments
NPI 1649976804 · CONOVER, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$635 in 33 payments from 13 companies in 2025. Trend: 2023 $450 · 2024 $479 · 2025 $635
Food & beverage: $635
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $107 |
| Lilly USA, LLC | 4 | $89 |
| AstraZeneca Pharmaceuticals LP | 4 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $68 |
| PFIZER INC. | 2 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 3 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Amgen Inc. | 2 | $31 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
Products named: Ozempic, AIRSUPRA, Kerendia, JARDIANCE, MOUNJARO, XIFAXAN, VOQUEZNA, GVOKE HYPOPEN.
Industry payments across NC — which companies pay providers there.
